Clinical Trial Update: A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for Janssen's JNJ-87801493 in combination with T-cell engagers for B-cell Non-Hodgkin lymphoma; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• JNJ-87801493
• T-cell engager (T-cell engager)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lymphoma, Non-Hodgkin | Phase 1 | Status: ACTIVE_NOT_RECRUITING